Wysokinski et al. also showed that the level of transferrin in the serum was elevated in the AMD group as opposed to the control group and described genetic polymorphisms in iron homeostasis genes as likely risk markers for AMD [29]. The gene discussed is TF; the disease is age-related macular degeneration.